201 related articles for article (PubMed ID: 16482461)
1. [HTA in the decision-making processes of health care institutions. Current state and relevant questions of regulatory health law].
Francke R; Hart D
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):241-50. PubMed ID: 16482461
[TBL] [Abstract][Full Text] [Related]
2. [The role of HTA in German health care. Do we need impact objectives?].
Gerhardus A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):233-40. PubMed ID: 16453136
[TBL] [Abstract][Full Text] [Related]
3. [Health economics and HTA].
Kulp W; Greiner W
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):257-63. PubMed ID: 16465516
[TBL] [Abstract][Full Text] [Related]
4. [The critical role of research evidence in the framework of health technology assessment].
Sauerland S
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):251-6. PubMed ID: 16477456
[TBL] [Abstract][Full Text] [Related]
5. [Epidemiological studies in the HTA evaluation process].
Behrens T; Ahrens W
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):264-71. PubMed ID: 16477457
[TBL] [Abstract][Full Text] [Related]
6. [The role of randomised controlled trials in the medical evaluation of routine procedures].
Lange S
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):272-7. PubMed ID: 16465518
[TBL] [Abstract][Full Text] [Related]
7. A short history of health technology assessment in Germany.
Perleth M; Gibis B; Göhlen B
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():112-9. PubMed ID: 19500440
[TBL] [Abstract][Full Text] [Related]
8. Toward a sustainable European Network for Health Technology Assessment. The EUnetHTA project.
Kristensen FB; Chamova J; Hansen NW
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):283-5. PubMed ID: 16453137
[TBL] [Abstract][Full Text] [Related]
9. [The German Network for Evidence-based Medicine -- DNEbM].
Perleth M; Lühmann D; Antes G
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):278-82. PubMed ID: 16465517
[TBL] [Abstract][Full Text] [Related]
10. Health technology assessment and primary data collection for reducing uncertainty in decision making.
Goeree R; Levin L; Chandra K; Bowen JM; Blackhouse G; Tarride JE; Burke N; Bischof M; Xie F; O'Reilly D
J Am Coll Radiol; 2009 May; 6(5):332-42. PubMed ID: 19394574
[TBL] [Abstract][Full Text] [Related]
11. Evidence-based decision-making 3: Health technology assessment.
O'Reilly D; Campbell K; Vanstone M; Bowen JM; Schwartz L; Assasi N; Goeree R
Methods Mol Biol; 2015; 1281():417-41. PubMed ID: 25694325
[TBL] [Abstract][Full Text] [Related]
12. Health technology assessment for radiologists: basic principles and evaluation framework.
Lim ME; O'Reilly D; Tarride JE; Burke N; Ferrusi IL; Campbell K; Goeree R
J Am Coll Radiol; 2009 May; 6(5):299-306. PubMed ID: 19394570
[TBL] [Abstract][Full Text] [Related]
13. A regulatory governance perspective on health technology assessment (HTA) in France: the contextual mediation of common functional pressures.
Barron AJ; Klinger C; Shah SM; Wright JS
Health Policy; 2015 Feb; 119(2):137-46. PubMed ID: 25458970
[TBL] [Abstract][Full Text] [Related]
14. Health technology assessment: a review of international activity and examples of approaches with computed tomographic colonography.
Husereau D; Morrison A; Battista R; Goeree R
J Am Coll Radiol; 2009 May; 6(5):343-52. PubMed ID: 19394575
[TBL] [Abstract][Full Text] [Related]
15. Health Technology Assessment-Informed Decision Making by the Federal Joint Committee/Institute for Quality and Efficiency in Health Care in Germany and the National Institute for Health and Care Excellence in England: The Role of Budget Impact.
Schaefer R; Hernández D; Bärnighausen T; Kolominsky-Rabas P; Schlander M
Value Health; 2023 Jul; 26(7):1032-1044. PubMed ID: 36921901
[TBL] [Abstract][Full Text] [Related]
16. [Innovation in health care: the role of HTA in the introduction of new technologies].
Bührlen B
Z Evid Fortbild Qual Gesundhwes; 2010; 104(10):703-8. PubMed ID: 21147431
[TBL] [Abstract][Full Text] [Related]
17. Is the National Institute for Health and Care Excellence (NICE) in England more 'innovation-friendly' than the Federal Joint Committee (G-BA) in Germany?
Schaefer R; Schlander M
Expert Rev Pharmacoecon Outcomes Res; 2019 Aug; 19(4):453-462. PubMed ID: 30556745
[No Abstract] [Full Text] [Related]
18. A regulatory governance perspective on Health Technology Assessment (HTA) in Sweden.
Shah SM; Barron A; Klinger C; Wright JS
Health Policy; 2014 May; 116(1):27-36. PubMed ID: 24655685
[TBL] [Abstract][Full Text] [Related]
19. Values and evidence colliding: health technology assessment in child health.
Ungar WJ; Prosser LA; Burnett HF
Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):417-9. PubMed ID: 23977967
[No Abstract] [Full Text] [Related]
20. [Experiences with and impact of health technology assessment on the German Standing Committee of physicians and patients].
Gibis B; Rheinberger P
Z Arztl Fortbild Qualitatssich; 2002 Feb; 96(2):82-90. PubMed ID: 11921610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]